World Journal of
Pharmaceutical and Life Sciences

REVIEW ON TREATMENT OF THYROID DISEASE IN PREGNANCY

Shreya Uday Mahajan*, Prajakta Deepak Suryawanshi, Sneha Kashinath Landge and Chaitali Chandrakant Kulkarni

ABSTRACT

Pregnancy-related thyroid dysfunction is a serious health issue that can have a negative impact on the health of the mother and the fetus. The goal of this review is to present a thorough examination of the current approaches of treating thyroid dysfunctions, such as thyroiditis, hypothyroidism, and hyperthyroidism, during pregnancy. Antithyroid drugs, such as propylthiouracil (PTU) in the first trimester and methimazole (MMI) later, are commonly used to treat hyperthyroidism, which is defined by an excess of thyroid hormone production. Careful monitoring is required to prevent fetal hypothyroidism or goiter. Levothyroxine is used to treat hypothyroidism, which is characterized by low thyroid hormone levels. This preserves euthyroid condition and promotes the best possible health for both the mother and the fetus. The therapy of thyroiditis varies according to the stage of the illness, frequently necessitating close observation and symptomatic treatment. The significance of routine thyroid function testing and individualized treatment regimens catered to the requirements of each patient is also covered in this study. It also covers the effects of untreated thyroid problems on the course of pregnancy and emphasizes new developments in treatment guidelines. The study emphasizes that in order to maximize care and enhance prognoses for pregnant women with thyroid illness, obstetricians, endocrinologists, and primary care physicians must collaborate across multidisciplinary fields..

[Full Text Article]   [Download Certificate]